Utah HB0390 authorizes the Huntsman Mental Health Institute to conduct a clinical study on psychedelic-assisted therapy for veterans with.

Utah HB0390 allows the Huntsman Mental Health Institute to research the safety and feasibility of psychedelic-assisted therapy for veterans with treatment-resistant PTSD. The Institute can accept donations to fund the study, which must begin by January 1, 2027, if sufficient funds are available. The study must comply with state and federal regulations, including FDA and DEA requirements. The Institute must report on the study's progress and submit a final report to the Health and Human Services Interim Committee.

Utah HB0390 authorizes the Huntsman Mental Health Institute to conduct a clinical study on psychedelic-assisted therapy for veterans with.

Utah HB0390 allows the Huntsman Mental Health Institute to research the safety and feasibility of psychedelic-assisted therapy for veterans with treatment-resistant PTSD. The Institute can accept donations to fund the study, which must begin by January 1, 2027, if sufficient funds are available. The study must comply with state and federal regulations, including FDA and DEA requirements. The Institute must report on the study's progress and submit a final report to the Health and Human Services Interim Committee.